Plasmepsin

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (09:50, 31 August 2023) (edit) (undo)
 
(22 intermediate revisions not shown.)
Line 1: Line 1:
-
{{STRUCTURE_3fns| right| PDB=3fns | SCENE= |CAPTION=Plasmepsin dimer witn Zn+2 ions, [[3fns]] }}
+
<StructureSection load='' size='350' side='right' caption='Plasmepsin II complex with a potential antimalarial drug (PDB entry [[4cku]])' scene='44/441867/Cv/1'>
-
[[Plasmepsin]] (Plm) is a hemoglobin-degrading enzyme produced by the plasmodium parasite. It is a potential target for anti-malaria drugs. It is an aspartic acid protease having 2 aspartic acid residues in the active site. Ten Plm isoforms are known which are named Plm I, II, etc and Histo-Aspartic Protease (HAP). ProPml II exhibits a large shift between its domains which renders the protease inactive. The images on the left and right correspond to one representative Plm structure, ''i.e.'' the Plasmepsin from ''Plasmodium falciparum'' ([[3fns]]).
+
== Function ==
 +
[[Plasmepsin]] (Plm) is a hemoglobin-degrading enzyme produced by the plasmodium parasite. It is an aspartic acid protease having 2 aspartic acid residues in the active site. Ten Plm isoforms are known which are named Plm I, II, etc and '''Histo-Aspartic Protease (HAP)'''.
-
<br />
+
*'''Proplasmepsin II''' exhibits a large shift between its domains which renders the protease inactive<ref>PMID:9886289</ref>.
-
{{TOC limit|limit=2}}
+
-
== 3D Structures of Plasmepsin ==
+
==Relevance ==
-
<br />
+
Plm is a potential target for anti-malaria drugs<ref>PMID:25719272</ref>.
-
<br />
+
-
<br />
+
-
<br />
+
-
<br />
+
-
Updated: {{REVISIONDAY2}}-{{REVISIONMONTH}}-{{REVISIONYEAR}} (DD-MM-YYYY)
+
== Structural highlights ==
 +
The active site of Plm II contains a <scene name='44/441867/Cv/4'>catalytic dyad of 2 Asp residues which interact with potential antimalarial inhibitor</scene><ref>PMID:24900843</ref>. <scene name='44/441867/Cv/5'>Whole active site</scene>. Water molecules are shown as red spheres.
 +
</StructureSection>
 +
==3D structures of plasmepsin==
-
===HAP===
+
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}}
 +
{{#tree:id=OrganizedByTopic|openlevels=0|
-
[[3fns]] – PfHAP - ''Plasmodium falciparum''<br />
+
*Histo-Aspartic Protease
-
[[3fnt]] – PfHAP + inhibitor pepstatin<br />
+
-
[[3fnu]] – PfHAP + KNI-10006<br />
+
-
===Plm I===
+
**[[3fns]], [[3qvc]], [[6kub]], [[6kuc]], [[6kud]] – PfHAP - ''Plasmodium falciparum''<br />
 +
**[[3fnt]] – PfHAP + pepstatin<br />
 +
**[[3fnu]], [[3qvi]] – PfHAP + inhibitor<br />
-
[[3qrv]] – PfPlm I residues 117-457<br />
+
*Plasmepsin I
-
[[3qs1]] - PfPlm I residues 117-457 + inhibitor
+
-
===Plm II===
+
**[[3qrv]] – PfPlm I residues 117-457<br />
 +
**[[3qs1]] - PfPlm I residues 117-457 + inhibitor
-
[[1lf4]] – PfPlm II<br />
+
*Plasmepsin II
-
[[3f9q]] – PfPlm II (mutant)<br />
+
-
[[2r9b]] – PfPlm II + peptide inhibitor<br />
+
-
[[1w6h]], [[2bju]], [[1lf2]], [[1lf3]], [[1lee]], [[2igx]], [[2igy]] – PfPlm II + inhibitor<br />
+
-
[[1w6i]], [[1xdh]], [[1xe5]], [[1xe6]], [[1me6]], [[1sme]] – PfPlm II + pepstatin derivative<br />
+
-
[[1m43]] - PfPlm II (mutant) + pepstatin derivative<br />
+
-
===ProPlm II===
+
**[[1lf4]] – PfPlm II<br />
 +
**[[3f9q]] – PfPlm II (mutant)<br />
 +
**[[2r9b]] – PfPlm II + peptide inhibitor<br />
 +
**[[1w6h]], [[2bju]], [[1lf2]], [[1lf3]], [[1lee]], [[2igx]], [[2igy]], [[4cku]], [[4y6m]], [[4z22]], [[5yia]], [[5yib]], [[5yic]], [[5yid]], [[5yie]], [[7qyh]] – PfPlm II + inhibitor<br />
 +
**[[4ya8]] – PfPlm II (mutant) + inhibitor<br />
 +
**[[7ve0]], [[7ve2]] – PfPlm II + drug<br />
 +
**[[1w6i]], [[1xdh]], [[1xe5]], [[1xe6]], [[1me6]], [[1sme]] – PfPlm II + pepstatin derivative<br />
 +
**[[1m43]] - PfPlm II (mutant) + pepstatin derivative<br />
-
[[1pfz]] - PfProPlm II<br />
+
*Plasmepsin IV
-
[[1miq]] – PvProPlm II – ''Plasmodium vivax''<br />
+
-
[[1qs8]] - PvPlm + pepstatin derivative<br />
+
-
===Plm IV===
+
**[[2anl]] – Plm IV + statine derivative – ''Plasmodium malariae''<br />
 +
**[[1ls5]] - PfPlm IV + pepstatin derivative<br />
-
[[2anl]] – Plm IV + statine derivative – ''Plasmodium malariae''<br />
+
*Plasmepsin V or aspartic protease PM5
-
[[1ls5]] - PfPlm IV + pepstatin derivative<br />
+
 +
**[[6c4g]] – PvPlm V + inhibitor<br />
 +
**[[4zl4]] – PvPlm V + transition state analog<br />
 +
 +
*Plasmepsin X
 +
 +
**[[7ry7]] – PvPlm X <br />
 +
**[[7tbc]], [[7tbd]], [[7tbe]], [[8dsr]] – PfPlm X + inhibitor<br />
 +
**[[7tbb]] – PfPlm X <br />
 +
 +
*Proplasmepsin II
 +
 +
**[[1pfz]], [[5bwy]] - PfProPlm II<br />
 +
**[[1miq]] – PvProPlm II – ''Plasmodium vivax''<br />
 +
**[[1qs8]], [[5i70]] - PvPlm II + pepstatin derivative<br />
 +
}}
 +
== References ==
 +
<references/>
[[Category:Topic Page]]
[[Category:Topic Page]]

Current revision

Plasmepsin II complex with a potential antimalarial drug (PDB entry 4cku)

Drag the structure with the mouse to rotate

3D structures of plasmepsin

Updated on 31-August-2023

References

  1. Bernstein NK, Cherney MM, Loetscher H, Ridley RG, James MN. Crystal structure of the novel aspartic proteinase zymogen proplasmepsin II from plasmodium falciparum. Nat Struct Biol. 1999 Jan;6(1):32-7. PMID:9886289 doi:10.1038/4905
  2. Huizing AP, Mondal M, Hirsch AK. Fighting malaria: structure-guided discovery of nonpeptidomimetic plasmepsin inhibitors. J Med Chem. 2015 Jul 9;58(13):5151-63. doi: 10.1021/jm5014133. Epub 2015 Mar 17. PMID:25719272 doi:http://dx.doi.org/10.1021/jm5014133
  3. Jaudzems K, Tars K, Maurops G, Ivdra N, Otikovs M, Leitans J, Kanepe-Lapsa I, Domraceva I, Mutule I, Trapencieris P, Blackman MJ, Jirgensons A. Plasmepsin inhibitory activity and structure-guided optimization of a potent hydroxyethylamine-based antimalarial hit. ACS Med Chem Lett. 2014 Jan 13;5(4):373-7. doi: 10.1021/ml4004952. eCollection, 2014 Apr 10. PMID:24900843 doi:http://dx.doi.org/10.1021/ml4004952

Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Alexander Berchansky, Joel L. Sussman, Jaime Prilusky

Personal tools